Every 10-Q that Greenland Mines Ltd. (GRML) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow GRML and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GRML filings page.
Greenland Mines Ltd (GRML) reports as a dual‑segment company, combining its legacy Biotech R&D programs (including ALS candidate KLTO‑202) with a new Mining segment focused on the Skaergaard palladium‑gold‑platinum project in southeast Greenland, where it now holds an 80% indirect interest.
In March 2026 it acquired Greenland Mines Corp. in an asset acquisition, recording $48.4 million of mineral exploration rights and licenses, and in June invested $3.68 million in AnorTech Inc. via a share exchange. Intangible assets rose to $48.7 million, driving total assets to $65.0 million as of June 30, 2026.
Operations remain pre‑revenue. The company recorded a six‑month net loss of $17.5 million (vs. $6.3 million a year earlier), including $17.0 million in operating and segment expenses and a $2.0 million biotech intangible impairment. Operating cash outflow was $11.8 million; cash was $9.3 million, supported by $14.8 million of equity financings year‑to‑date.
Management discloses substantial doubt about the company’s ability to continue as a going concern without additional capital and notes an ongoing Nasdaq minimum bid‑price deficiency, with possible use of a stockholder‑approved reverse split to aid compliance. Skaergaard and other mineral properties remain non‑producing, with Mineral Resources but no SEC‑defined Mineral Reserves.
Greenland Mines Ltd (GRML) filed an amended quarterly report for the three months ended March 31, 2026, reflecting a strategic pivot from pure biotech to a dual focus on biotechnology and mining. The company completed an asset acquisition of Greenland Mines Corp., recording $48.4 million of mineral rights and exploration licenses related to the Skaergaard Project in Greenland and issuing 47,940 Series C preferred shares as consideration.
The company remains pre-revenue and reported a widened net loss of $13.9 million versus $2.1 million a year earlier, driven by sharply higher general and administrative expenses, professional fees, $5.1 million of share-based compensation, a $2.0 million impairment of biotech-related intangible assets, and a $2.3 million increase in warrant liability fair value. Cash and cash equivalents were $10.0 million, supported by $7.75 million of private placement proceeds, but operating cash outflows were $5.0 million.
Management discloses an accumulated deficit of about $35.0 million and states there is substantial doubt about the company’s ability to continue as a going concern without additional financing. Nasdaq has granted an extension until September 14, 2026 to regain the $1.00 minimum bid price. Material weaknesses in internal control over financial reporting, including inadequate accounting resources and segregation of duties, remain unresolved. The amendment primarily revises disclosures around mineralization estimates and certain MD&A discussions in response to SEC staff comments.
Greenland Mines Ltd reported a much larger quarterly loss as it pivoted into mining. For the three months ended March 31, 2026, the company generated no revenue and recorded a net loss of $13,857,203, compared with $2,116,726 a year earlier, driven by higher general and administrative, professional, and share-based compensation expenses plus a $2,045,253 impairment of biotech intangibles.
Cash and cash equivalents were $10,002,477, with net cash used in operating activities of $4,971,143. Management states there is substantial doubt about the company’s ability to continue as a going concern without additional financing. During the quarter, Greenland Mines completed a forward merger to acquire mineral rights and exploration licenses for the Skaergaard Project, recognizing indefinite-lived mineral intangibles of $48,416,474 and creating a new Mining segment alongside its Biotech operations.
The company raised gross proceeds of about $7,750,000 via a private placement and ended the period with 121,238,660 common shares outstanding. Nasdaq granted an extension until September 14, 2026 for the stock to regain the $1.00 minimum bid price. Subsequent to quarter-end, Greenland Mines agreed to acquire Neo North Star Resources, owner of the Sarfartoq rare earth project, for $35 million, split between $20 million in cash and $15 million in new common shares.